Showing results (61-70 of 140) with videos related to
Sort By:
Pageof 14
Annales De Cardiologie Et D'Angeiologie|October 20, 2012
[Management of ST-elevation myocardial infarction in 2012]G Cayla, J Silvain, P Ecollan, et al.Journal of the American College of Cardiology|August 10, 2000
Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstentsR Choussat, A J Black, I Bossi, et al.Cardiovascular Research|December 23, 1998
Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogsR Choussat, L Hittinger, F Barbe, et al.QJM : Monthly Journal of the Association of Physicians|May 1, 2012
Current antiplatelet options for NSTE-ACS patientsG Cayla, J Silvain, S A O'Connor, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|May 19, 2000
[Percutaneous coronary angioplasty via the radial artery. Feasibility and safety]R Choussat, A J Black, B Cassagneau, et al.Catheterization and Cardiovascular Diagnosis|April 1, 1992
Systemic embolism as a complication of percutaneous mitral valvuloplastyG Drobinski, G Montalescot, J Evans, et al.International Journal of Cardiology|August 1, 1988
Diagnosis of primary cardiac sarcoma. Report of 4 cases and review of the literatureG Montalescot, C Chapelon, G Drobinski, et al.Journal Des Maladies Vasculaires|October 27, 2001
[Whole blood viscosity measurement in acute myocardial infarction: feasibility and significance]F Philippe, C Lacombe, C Bucherer, et al.Journal of the American College of Cardiology|July 1, 1994
Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirinG Montalescot, J Maclouf, G Drobinski, et al.Circulation|July 1, 1995
Fibrinogen after coronary angioplasty as a risk factor for restenosisG Montalescot, A Ankri, E Vicaut, et al.Pageof 14